Zinc released from injured cells is acting via the Zn2+-sensing receptor, ZnR, to trigger signaling leading to epithelial repair
In February 2025, the number of Ozempic lawsuit cases rose to 1,443, reflecting an increase of 112 cases compared to January 2025, where the total stood at 1,331
Over a 36-month period, the incidence of NAION in semaglutide users was 8.9%, compared to just 1.8% in the non-GLP-1 RA cohort
While prescription weight loss medications have been on the market for decades, such as phentermine, the newer GLP-1s, including Ozempic (used off-label for weight loss) and Wegovy, have been generally shown to be more effective than previous treatments